Menorrhagia Screen without Consultation
Use
This panel includes a series of coagulation tests—activated partial thromboplastin time (aPTT), prothrombin time with INR, Factor XI activity, von Willebrand factor antigen, ristocetin cofactor activity, and Factor VIII activity—to evaluate potential bleeding disorders in individuals with heavy menstrual bleeding (menorrhagia). It is identical to the “Menorrhagia Screen with Consultation” except that it excludes a coagulation consultation.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
Automated Analyzer (Coagulation)
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1 mL platelet‑poor plasma collected in each of three separate 3.2% sodium citrate (light blue‑top) tubes
Minimum Volume
0.5 mL (x3)
Container
sodium citrate (light blue‑top) tubes
Collection Instructions
Collect blood in three sodium citrate tubes (light blue‑top) tubes must be filled to capacity to insure correct blood to anticoagulant ratio. Centrifuge whole blood at 1500g for 15 minutes. Avoiding the buffy coat, transfer plasma using a plastic pipette into a new plastic tube and repeat centrifugation. Aliquot plasma using a plastic pipette into 3 new plastic vials and freeze.
Other tests from different labs that may be relevant